Sturm Ruger & Co Inc: 5%+ holders

Sturm Ruger & Co Inc has 12 Schedule 13D or 13G filings on record since 2025-07-29. 2 holders' latest filing reports 5% or more of common stock, $1.00 par value per share. Each figure below is the holder's own, as filed, with the filing linked.

Stated intent

Intent stated in Item 4 Beretta Holding S.A.

On March 31, 2026, the Reporting Person's counsel at Olshan Frome Wolosky LLP sent a letter to the Issuer's counsel at White & Case LLP (the "March 31 Letter") in which, among other things, it expressed the Reporting Person's deep dismay that the Issuer's Board of Directors (the "Board") chose to reject the Reporting Person's request for a waiver to the poison pill, and therefore obstruct the Reporting Person from proceeding with its cash tender offer to the Issuer's shareholders at a premium.From Item 4 of the SCHEDULE 13D/A filed 2026-03-31

Intent stated in Item 4 Beretta Holding S.A.

This Item 4 is hereby amended to include the following: On February 24, 2026, the Reporting Person sent a letter to the Issuer setting forth its intention to nominate four directors for election at the Issuer's 2026 annual meeting of shareholders (the "Annual Meeting") and serving as notice of nomination in accordance with the Issuer's amended and restated bylaws and Rule 14a-19(b) under the Securities Exchange Act of 1934, as amended.From Item 4 of the SCHEDULE 13D/A filed 2026-02-26

Holders

Purpose of Transaction (Item 4)

Beretta Holding S.A.

Item 4 is hereby amended to add the following: As previously disclosed in Amendment No. 6 to the Schedule 13D, on May 2, 2026, the Reporting Person entered into a cooperation agreement with the Issuer (the "Agreement"). Pursuant to the Agreement, and upon the terms and subject to the conditions thereof and following the satisfaction of the Regulatory Conditions (as defined in the Agreement), on September 17, 2026, the Reporting Person commenced a tender offer (the "Tender Offer") to purchase up to 2,400,184 shares of the Issuer's issued and outstanding Common Stock, for a cash price per share of $44.80. If the Tender Offer is fully subscribed, the Reporting Person or its affiliate will purchase 2,400,184 Shares, which would represent approximately 15.02% of the outstanding Shares and would result in the Reporting Person or its affiliate beneficially owning an aggregate of approximately 3,987,184 Shares, which would represent approximately 24.95% of the outstanding Shares. The Tender Offer and withdrawal rights will expire at one minute after 11:59 p.m., New York City time, on October 15, 2026, unless the Tender Offer is extended. The Tender Offer is not subject to any financing condition and is not conditioned on any minimum number of Shares being tendered. The Tender Offer is subject to the satisfaction of certain customary conditions. The Reporting Person is seeking to acquire the Shares in the Tender Offer for investment purposes. The Tender Offer is not seeking to …The first part of Item 4 of the SCHEDULE 13D/A filed 2026-09-17; the filing has the rest

Timeline

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

All recent stakesThat week's stakes